What we do
Pharmaceuticals with a difference
With a guiding principle of working to improve your health, we deliver pharmaceuticals that make a real difference to people’s health.
Here at AFT Pharmaceuticals, our company vision is simple: to develop innovative products that help people. We do this by seeing opportunities that others may have missed, and by filling gaps in the market with innovative products that can provide positive health outcomes for those who need them.
Our success is built on research and development. R&D is more than ‘corporate speak’ for us: it’s at the heart of what we do in developing new products or improving existing ones. This has allowed us to successfully grow our business year after year, and crucially, to meet the health needs of people in Australasia and around the globe.
“At AFT Pharmaceuticals, we remain committed to reinvest into R&D to help people across the world.”
Hartley Atkinson, Founder and Managing Director
Join our team
We’re always looking for talented people, please have a look at the careers we currently have available.
Social responsibility
We don’t just give back. We give health
We don’t speak for others, but as a successful company, we think it’s important to give back to those who most need it.
And that’s why we’ve reached out in developing nations to help deliver healthcare that developed nations take for granted. This includes Eyes4Everest, the AusViet Charity Foundation, and helping Carmelite nuns in East Timor and the Wesleyan Mission to Bougainville.
May 1, 2024
AFT Licenses Maxigesic® IV in Brazil
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT, Massey Ventures, Gilles McIndoe to develop scar treatment
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT makes further progress in international markets
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….